You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 30, 2025

Drug Price Trends for TRIAMTERENE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TRIAMTERENE

Average Pharmacy Cost for TRIAMTERENE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP 00527-1632-01 0.11814 EACH 2025-03-19
TRIAMTERENE 50 MG CAPSULE 66993-0831-02 6.33511 EACH 2025-03-19
TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB 72888-0095-05 0.11168 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 3 of 3 entries

Best Wholesale Price for TRIAMTERENE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
DYRENIUM 100MG CAP Amdipharm Limited 59212-0003-01 100 1260.70 12.60700 EACH 2023-01-01 - 2026-09-28 FSS
DYRENIUM 50MG CAP Amdipharm Limited 59212-0002-01 100 1196.68 11.96680 EACH 2022-01-01 - 2026-09-28 FSS
DYRENIUM 100MG CAP Amdipharm Limited 59212-0003-01 100 837.40 8.37400 EACH 2021-09-29 - 2026-09-28 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for Triamterene

Overview of Triamterene

Triamterene is a potassium-sparing diuretic commonly used to treat conditions such as edema and high blood pressure. It is often prescribed alone or in combination with other diuretics like hydrochlorothiazide.

Market Size and Growth

The Triamterene API Market has experienced significant growth in recent years and is expected to continue this trend from 2023 to 2031. The market analysis indicates robust growth rates driven by various factors, including increasing demand in the medical and pharmaceutical sectors, as well as in scientific research[1].

Market Segmentation

The Triamterene API Market is segmented based on several criteria:

Type

The market is categorized into different purity levels of triamterene, such as 0.99, 0.995, 0.999, and others. Each type has its own market dynamics and demand patterns[1].

Application

Triamterene is used in two primary applications: medical pharmaceuticals and scientific research. The medical pharmaceutical segment is the largest consumer, given the drug's widespread use in treating edema and hypertension[1].

Geographical Regions

The market is analyzed across various geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. Each region has its own market size, growth rate, and specific drivers and restraints[1].

Market Dynamics

Drivers

  • Increasing Demand: The growing need for effective diuretics in the treatment of edema and hypertension drives the demand for triamterene.
  • Advancements in Healthcare: Improvements in healthcare infrastructure and access to medications in various regions contribute to market growth.
  • Research and Development: Continuous research in the pharmaceutical sector, including the development of new formulations and combinations, boosts the market[1].

Restraints

  • Price Increases: Recent price hikes in the pharmaceutical industry, including an 18% increase in triamterene/HCTZ combinations, can impact consumer affordability and market growth[3].
  • Regulatory Challenges: Strict regulatory environments and the need for compliance can slow down market expansion.
  • Competition: The presence of other diuretics and generic alternatives can pose competition to triamterene[1].

Opportunities

  • Emerging Markets: Expanding into emerging markets, particularly in Asia-Pacific and South America, offers significant growth opportunities.
  • Combination Therapies: Developing combination therapies with other diuretics, like hydrochlorothiazide, can enhance market penetration[1].

Challenges

  • Price Volatility: Frequent price increases, such as the recent hikes in January 2024, can create uncertainty and affect market stability[3].
  • Stock Shortages: Potential stock shortages due to supply chain issues can impact the availability and pricing of triamterene[2][5].

Price Projections

Current Pricing

The cost of triamterene varies based on the dosage and form. For example, a supply of 100 capsules of triamterene 50 mg can cost around $1,023, depending on the pharmacy[2].

Price Increases

Recent trends show significant price increases in the pharmaceutical industry. For instance, in January 2024, prices of several brand-name drugs, including diuretics like triamterene/HCTZ, increased by up to 33%[3].

Future Pricing

Given the current trends, it is likely that the prices of triamterene will continue to rise, albeit at a rate that may be mitigated by the efforts of Pharmacy Benefit Managers (PBMs) to negotiate lower costs and drive competition[3].

Impact of PBMs

Pharmacy Benefit Managers play a crucial role in managing the cost of medications for health plans, employers, and patients. Despite the increasing list prices set by pharmaceutical companies, PBMs work to lower costs through negotiations and by incentivizing the use of less expensive alternatives. This can help stabilize the market and make triamterene more affordable for consumers[3].

Regional Market Analysis

The market for triamterene is diverse across different regions:

North America and Europe

These regions have well-established healthcare systems and a high demand for diuretics, contributing to a significant market share.

Asia-Pacific

This region is expected to see rapid growth due to increasing healthcare infrastructure and a large patient population.

South America and Middle-East and Africa

These regions offer emerging market opportunities, driven by growing healthcare needs and improving economic conditions[1].

Consumer Behavior and Economic Impact

Consumer behavior is influenced by the affordability and availability of triamterene. High prices can lead to reduced demand, while efforts by PBMs to lower costs can increase market penetration.

The economic impact of triamterene pricing is significant, especially for health plans and Medicare. For example, the potential annual cost to Medicare for certain medications, if widely adopted, can be substantial, highlighting the need for cost management strategies[3].

Technological and Regulatory Trends

Technological advancements in the pharmaceutical industry, such as the development of new formulations and delivery systems, can influence the market for triamterene. Regulatory changes, including those related to pricing and reimbursement, also play a crucial role in shaping market dynamics[4].

Key Takeaways

  • Market Growth: The Triamterene API Market is expected to grow significantly from 2023 to 2031.
  • Price Increases: Recent and anticipated price hikes in the pharmaceutical industry may impact the affordability of triamterene.
  • Regional Variations: Market dynamics vary across different geographical regions.
  • Role of PBMs: Pharmacy Benefit Managers are crucial in managing costs and making medications more affordable.
  • Technological and Regulatory Trends: These factors continue to shape the market and influence pricing and availability.

FAQs

Q1: What is triamterene used for? Triamterene is used to treat conditions such as edema and high blood pressure. It is a potassium-sparing diuretic.

Q2: How much does triamterene cost? The cost of triamterene can vary, but a supply of 100 capsules of triamterene 50 mg can cost around $1,023, depending on the pharmacy.

Q3: What are the main segments of the triamterene market? The market is segmented by type (purity levels), application (medical pharmaceuticals and scientific research), and geographical regions.

Q4: Why are prices of triamterene increasing? Prices are increasing due to various factors, including annual price hikes by pharmaceutical companies and supply chain issues.

Q5: How do PBMs impact the cost of triamterene? Pharmacy Benefit Managers work to lower costs by negotiating with drugmakers, driving competition, and incentivizing the use of less expensive medicines.

Sources

  1. Market Research Intellect: Global Triamterene API Market Size, Scope And Forecast Report.
  2. Drugs.com: Triamterene Prices, Coupons, Copay Cards & Patient Assistance.
  3. MedCity News: Pharma Just Increased the Price of Hundreds of Drugs. PBMs are Minimizing the Impact for Health Plans, Employers, and Patients.
  4. Cognitive Market Research: Global Triamterene Tablet Market Report 2024 Edition.
  5. Drugs.com: Hydrochlorothiazide/triamterene Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.